Author

Paavo V. H. Raittinen

Aalto UniversityORCID 0000-0003-4207-8415Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Aino SiltariiD· 1 shared Heimo Syvälä· 1 shared Matti NykteriD· 1 shared Merja Bläuer· 1 shared Milja I. Paloneva· 1 shared Pauliina IlmoneniD· 1 shared Reetta NätkiniD· 1 shared Teemu Johannes MurtolaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aino SiltariORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 30, 2025

Phenotypic and transcriptomic characterization of bicalutamide and enzalutamide resistance in castration-resistant prostate cancer cells

Reetta Nätkin, Milja I. Paloneva, Paavo V. H. Raittinen…·Teemu Johannes Murtola

This study characterizes transcriptomic and phenotypic changes in prostate cancer cells developing resistance to bicalutamide and enzalutamide, showing treatment sequence affects drug resistance and docetaxel sensitivity.

DOI 10.1101/2025.05.30.656961

humanproteomics

𝕏 PostBluesky